The winners of the 28th National Biotechnology and Medical Care Quality Awards and the SNQ (Symbol of National Quality) were officially announced yesterday (Jan 7). Dr. Chen Wei-chao, Convener of the SNQ, announced that 290 teams passed the rigorous certification in the service category, resulting in 6 Silver and 12 Bronze awards. Notably, several achievements have been adopted by the World Health Organization (WHO) and incorporated into medical textbooks.
Global Impact of Taiwan’s Clinical Innovation: Dr. Chen highlighted critical clinical breakthroughs, including Boron Neutron Capture Therapy (BNCT) for cancer, microinvasive aortic surgery, and high-difficulty renal cancer resections. In the digital health sector, molecular pathology, the National Eye Bank, and AI-driven diagnostics have provided essential resources for modern medicine. Furthermore, three clinical evidences have influenced international guidelines, and five outcomes have been integrated into global treatment protocols.
Strategic Internationalization: To deepen international ties, SNQ officially signed a strategic cooperation agreement with ICHOM (International Consortium for Health Outcomes Measurement) last December. Dr. Chang De-ming, Co-convener, announced the formation of an "International Certification Committee" to systematize Taiwan’s clinical data and allow international organizations to view the objective indicators and global positioning of Taiwanese hospitals at a glance.
Clinical Highlights from Awardees:
Resource: SNQ國家生技醫療品質獎揭曉！台灣「5項成果」被WHO採用，影響全球照護模式
